Repligen Statistics
Total Valuation
Repligen has a market cap or net worth of $10.39 billion. The enterprise value is $10.27 billion.
| Market Cap | 10.39B |
| Enterprise Value | 10.27B |
Important Dates
The next confirmed earnings date is Tuesday, October 27, 2026, before market open.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Repligen has 56.44 million shares outstanding. The number of shares has increased by 0.94% in one year.
| Current Share Class | 56.44M |
| Shares Outstanding | 56.44M |
| Shares Change (YoY) | +0.94% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 0.32% |
| Owned by Institutions (%) | 124.76% |
| Float | 53.47M |
Valuation Ratios
The trailing PE ratio is 252.36 and the forward PE ratio is 81.82. Repligen's PEG ratio is 3.86.
| PE Ratio | 252.36 |
| Forward PE | 81.82 |
| PS Ratio | 13.24 |
| Forward PS | 10.80 |
| PB Ratio | 4.92 |
| P/TBV Ratio | 15.98 |
| P/FCF Ratio | 92.83 |
| P/OCF Ratio | 77.07 |
| PEG Ratio | 3.86 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 71.30, with an EV/FCF ratio of 91.76.
| EV / Earnings | 247.34 |
| EV / Sales | 13.09 |
| EV / EBITDA | 71.30 |
| EV / EBIT | 157.30 |
| EV / FCF | 91.76 |
Financial Position
The company has a current ratio of 9.05, with a Debt / Equity ratio of 0.33.
| Current Ratio | 9.05 |
| Quick Ratio | 7.30 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 3.67 |
| Debt / FCF | 6.17 |
| Interest Coverage | 2.74 |
Financial Efficiency
Return on equity (ROE) is 1.99% and return on invested capital (ROIC) is 2.60%.
| Return on Equity (ROE) | 1.99% |
| Return on Assets (ROA) | 1.40% |
| Return on Invested Capital (ROIC) | 2.60% |
| Return on Capital Employed (ROCE) | 2.32% |
| Weighted Average Cost of Capital (WACC) | 9.71% |
| Revenue Per Employee | $392,551 |
| Profits Per Employee | $20,770 |
| Employee Count | 2,000 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 2.12 |
Taxes
In the past 12 months, Repligen has paid $10.61 million in taxes.
| Income Tax | 10.61M |
| Effective Tax Rate | 20.35% |
Stock Price Statistics
The stock price has increased by +24.10% in the last 52 weeks. The beta is 1.08, so Repligen's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | +24.10% |
| 50-Day Moving Average | 175.47 |
| 200-Day Moving Average | 144.08 |
| Relative Strength Index (RSI) | 55.48 |
| Average Volume (20 Days) | 1,342,735 |
Short Selling Information
The latest short interest is 7.58 million, so 13.43% of the outstanding shares have been sold short.
| Short Interest | 7.58M |
| Short Previous Month | 6.71M |
| Short % of Shares Out | 13.43% |
| Short % of Float | 14.18% |
| Short Ratio (days to cover) | 7.18 |
Income Statement
In the last 12 months, Repligen had revenue of $785.10 million and earned $41.54 million in profits. Earnings per share was $0.73.
| Revenue | 785.10M |
| Gross Profit | 422.67M |
| Operating Income | 65.32M |
| Pretax Income | 52.15M |
| Net Income | 41.54M |
| EBITDA | 144.10M |
| EBIT | 65.32M |
| Earnings Per Share (EPS) | $0.73 |
Balance Sheet
The company has $810.45 million in cash and $690.94 million in debt, with a net cash position of $119.51 million or $2.12 per share.
| Cash & Cash Equivalents | 810.45M |
| Total Debt | 690.94M |
| Net Cash | 119.51M |
| Net Cash Per Share | $2.12 |
| Equity (Book Value) | 2.11B |
| Book Value Per Share | 37.43 |
| Working Capital | 1.07B |
Cash Flow
In the last 12 months, operating cash flow was $134.86 million and capital expenditures -$22.90 million, giving a free cash flow of $111.97 million.
| Operating Cash Flow | 134.86M |
| Capital Expenditures | -22.90M |
| Depreciation & Amortization | 78.78M |
| Net Borrowing | n/a |
| Free Cash Flow | 111.97M |
| FCF Per Share | $1.98 |
Margins
Gross margin is 53.84%, with operating and profit margins of 8.32% and 5.29%.
| Gross Margin | 53.84% |
| Operating Margin | 8.32% |
| Pretax Margin | 6.64% |
| Profit Margin | 5.29% |
| EBITDA Margin | 18.35% |
| EBIT Margin | 8.32% |
| FCF Margin | 14.26% |
Dividends & Yields
Repligen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.94% |
| Shareholder Yield | -0.94% |
| Earnings Yield | 0.40% |
| FCF Yield | 1.08% |
Analyst Forecast
The average price target for Repligen is $197.95, which is 7.48% higher than the current price. The consensus rating is "Buy".
| Price Target | $197.95 |
| Price Target Difference | 7.48% |
| Analyst Consensus | Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (3Y) | 19.21% |
| EPS Growth Forecast (3Y) | 26.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Repligen has an Altman Z-Score of 6.45 and a Piotroski F-Score of 7.
| Altman Z-Score | 6.45 |
| Piotroski F-Score | 7 |